240 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

Fill in a starting date and a closing date for the period your query is about: DD-MM-YYYY

You can select a specific type of a publication you are looking for, such as press releases or speeches

Roflumilast (Daxas®) for maintenance treatment of severe chronic obstructive lung disease (COPD)

Zorginstituut Nederland has carried out an assessment of whether roflumilast (Daxas®) is interchangeable with a drug currently ...

Report | 31-07-2018

SGLT2 inhibitors for the treatment of type 2 diabetes: relaxing List 2 conditions

Zorginstituut Nederland has carried out a substantive assessment of whether the existing list 2 conditions for SGLT2 inhibitors ...

Report | 31-07-2018

Teduglutide (Revestive®) for the treatment of short bowel syndrome

The Minister of Health, Welfare and Sport (VWS) has asked Zorginstituut Nederland to carry out an assessment of teduglutide ...

Report | 31-07-2018

Obeticholic acid (Ocaliva®) for the treatment of primary biliary cholangitis

Zorginstituut Nederland carried out an assessment of whether obeticholic acid (Ocaliva®) is interchangeable with a drug currently ...

Report | 18-07-2018

Cariprazine (Reagila®) for the treatment of schizophrenia

The Minister of Health, Welfare and Sport (WVS) asked Zorginstituut Nederland (National Health Care Institute) to carry out a ...

Report | 04-06-2018

Dimethyl fumarate (Skilarence®) for the treatment of plaque psoriasis in adults

The Minister of Health, Welfare and Sport (WVS) asked Zorginstituut Nederland (National Health Care Institute) to carry out an ...

Report | 09-05-2018

Flash Glucose Monitoring (FGM)

In this report Zorginstituut Nederland (National Health Care Institute) assesses whether Flash Glucose Monitoring (FGM) complies ...

Report | 30-04-2018

Rolapitant (Varuby®) for the prevention of delayed nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in adults

Zorginstituut Nederland has carried out an assessment of the medicinal product rolapitant (Varuby®). The GVS report concludes ...

Report | 17-04-2018

Belimumab (Benlysta®) for the treatment of adult patients with auto-antibody-positive systemic lupus erythematosus (SLE)

Zorginstituut Nederland has carried out an assessment of the medicinal product subcutaneous belimumab (Benlysta®) and a ...

Report | 29-03-2018

Fampridine (Fampyra®) in cases of multiple sclerosis (MS)

Zorginstituut Nederland carried out an assessment of the medicinal product fampridine (Fampyra®). Based on the outcomes of the ...

Report | 01-03-2018